<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24706" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mammoscintigraphy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ranzenberger</surname>
            <given-names>Logan R.</given-names>
          </name>
          <aff>Michigan State Un, McLaren Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Booth</surname>
            <given-names>Kristin A.</given-names>
          </name>
          <aff>Michigan State University, POH Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Logan Ranzenberger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kristin Booth declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24706.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Breast cancer is increasing in incidence and is one of the leading types of cancer. Once thought to be mostly a disease of elderly females, there is an increase in the incidence of breast cancer in women during their third and fourth decades of life. With increasing awareness, screening has become more prevalent, which in turn has increased the overall number of positive findings and subsequent testing. This activity reviews the applications of mammoscintigraphy in medicine today and highlights its advantages and disadvantages in the management of patients with breast pathology on screening or initial diagnostic studies.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the indications for mammoscintigraphy.</p></list-item><list-item><p>Describe the preparation and technique required for mammoscintigraphy.</p></list-item><list-item><p>Outline potential complications of mammoscintigraphy.</p></list-item><list-item><p>Identify interprofessional team strategies for improving care coordination to advance mammoscintigraphy and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24706&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24706">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24706.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Breast cancer is increasing in incidence and is one of the leading types of cancer. Once thought to be mostly a disease of elderly females, there is an increase in the incidence of breast cancer in women during their third and fourth decades of life. With increasing awareness, screening has become more prevalent, which in turn has increased the overall number of positive findings. Additionally, post-treatment monitoring increases with an overall increase in studies and survival rates. In an effort to decrease the morbidity and mortality of breast cancer, technological advances in breast imaging have been developed and are continuing to expand to detect breast cancers earlier. Methods of examination for breast cancer include self physical examination, physician physical examination, mammogram, tomography, ultrasound, magnetic resonance imaging (MRI), and positron emission tomography (PET). Another less commonly known and&#x000a0;rarely used modality is scintimammography or mammoscintigraphy. Scintimammography is a type of nuclear medicine imaging, which has been considered adjuvant to mammography specifically for cases containing post-surgical changes, indeterminate mammogram findings, post neoadjuvant chemotherapy follow-up, and suspected multifocal disease. MRI of the breast has largely taken the place of scintimammography because it can provide similar information and more such as a high-quality preoperative evaluation. Currently, clinicians have not decided on definite indications for scintimammography, resulting in many studies evaluating its utility.<xref ref-type="bibr" rid="article-24706.r1">[1]</xref><xref ref-type="bibr" rid="article-24706.r2">[2]</xref><xref ref-type="bibr" rid="article-24706.r3">[3]</xref><xref ref-type="bibr" rid="article-24706.r4">[4]</xref></p>
        <p>Studies have attempted to define the importance of scintimammography by comparing statistical data, including positive predictive values, false negatives, and false positives. The positive predictive value is low for mammograms, given the higher rates of false positives, but when combined with another modality, the positive predictive value will increase, which improves patient care and satisfaction overall.&#x000a0;</p>
        <p>Breast malignancies have been shown to have increased uptake of radiopharmaceuticals as compared to normal breast parenchyma. The diagnostic evaluation consists of intravenous injection of technetium 99m sestamibi (technetium 99m - DMSA or technetium 99m MDP can also be used but are less sensitive) with subsequent imaging of the breasts.<xref ref-type="bibr" rid="article-24706.r5">[5]</xref></p>
      </sec>
      <sec id="article-24706.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Normal distribution of technetium 99m sestamibi (the most commonly used radiopharmaceutical for scintimammography) is in the salivary glands, thyroid, myocardium, liver, and gallbladder.</p>
        <p>Any uptake of radiopharmaceutical greater than the average breast parenchyma is suspicious for malignancy. If the breast demonstrates mild, homogenous uptake of the radiopharmaceutical, it is considered a normal study. Patchy, widespread uptake likely is not indicative of malignancy. Evaluation of the axilla is important for interpreting potential metastasis to axillary lymph nodes in the presence of an ipsilateral focal area of increased uptake suggesting primary malignancy. Axillary folds will demonstrate increased uptake as an artifact and should be considered normal but can be a pitfall, and lateral imaging should be used to identify its superficial location and linear appearance.<xref ref-type="bibr" rid="article-24706.r6">[6]</xref></p>
      </sec>
      <sec id="article-24706.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Indications for scintimammography are debated given that MRI is currently the more preferred modality for similar indications; however, the most commonly stated reasons scintimammography is performed include equivocal, suspicious, or difficult to interpret mammograms and potential multifocal breast cancer. Additionally, patients with breast implants, axillary lymph node metastasis of an adenocarcinoma of unknown primary origin, and monitoring response to neoadjuvant chemotherapy.<xref ref-type="bibr" rid="article-24706.r7">[7]</xref><xref ref-type="bibr" rid="article-24706.r8">[8]</xref><xref ref-type="bibr" rid="article-24706.r9">[9]</xref><xref ref-type="bibr" rid="article-24706.r10">[10]</xref></p>
      </sec>
      <sec id="article-24706.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications for scintimammography are also currently being debated, with most of these being relative contraindications. Pregnant or lactating women would&#x000a0;pose a high risk for the fetus and/or infant&#x000a0;regarding radiation exposure. Scintimammography should not be performed if there is a history of recent surgical intervention, including cyst aspiration, fine needle aspiration, core needle biopsy, and excisional biopsy, with&#x000a0;the suggestion to wait 2 weeks for minor procedures and up to six weeks for major procedures. Appropriate delay in the examination is recommended to minimize the chances of false positives from increased uptake in the post-surgical reactive tissues. Examination during menses should also be avoided, as well as hypersensitivity to technetium 99m.<xref ref-type="bibr" rid="article-24706.r11">[11]</xref></p>
      </sec>
      <sec id="article-24706.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>A standard scintillation camera with a low-energy/high-energy collimator is used. A symmetric 10% energy window is used, centered over the 140 keV photopeak of technetium 99m.<xref ref-type="bibr" rid="article-24706.r11">[11]</xref></p>
      </sec>
      <sec id="article-24706.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Radiologists, nuclear medicine physicians, nuclear medicine technicians, cyclotron engineers/workers, and scheduling departments must coordinate activity&#x000a0;to set up and&#x000a0;obtain a scintimammogram. All members of the interprofessional healthcare team play a vital role in carrying out the task.</p>
      </sec>
      <sec id="article-24706.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>No specific preparation is needed for the patient to&#x000a0;have&#x000a0;a scintimammogram. A nuclear medicine technologist will be an asset to assist in the explanation and execution of the examination. It should be ensured that the patient is capable of lying prone on a hard surface with the arms extended above the head before the procedure is started. The patient should wear a hospital gown and remove all clothing and jewelry.</p>
        <p>Quality control should be performed according to the general guidelines issued by the Society of Nuclear Medicine&#x000a0;for the scintillation camera.<xref ref-type="bibr" rid="article-24706.r11">[11]</xref></p>
      </sec>
      <sec id="article-24706.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Imaging can be obtained in either planar and/or single-photon emission computed tomography. Intravenous injection with an indwelling catheter or butterfly needle of 20&#x000a0;to 30 mCi of technetium 99m into a vein of the upper extremity should be contralateral to the breast of concern. If there are suspicious bilateral findings, the lower extremity is then injected. Approximately 10 mL of saline flush should follow.</p>
        <p>Prone positioning is appropriate with the non-pathological breast compressed against the table to prevent the dependent breast from&#x000a0;artifacts from the contralateral breast. The arms are raised over the head with the head turned away from the detector to minimize artifacts. The detector is placed against the patient.</p>
        <p>The patient should be imaged 5&#x000a0;to 10 minutes after injection. Planar images to be obtained include prone lateral (including the breast, axilla, and anterior chest wall), prone posterior oblique, and anterior upright/supine chest (includes bilateral breasts and axillae). If a marker is desired, it should be placed once the breast is in the proper position; otherwise, the abnormality could change relative to the marker.</p>
        <p>The breast tissue is near myocardial tissue, which is an organ that takes up technetium 99m, so post-procession count subtraction should be obtained.<xref ref-type="bibr" rid="article-24706.r11">[11]</xref></p>
      </sec>
      <sec id="article-24706.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The procedure is relatively non-invasive with few adverse effects; however, potential complications could include extravasation of radiopharmaceuticals and allergic reaction to radiopharmaceuticals. Extravasation of technetium 99m has not been shown to cause significant harmful effects to the tissue involved, and usually, surgical intervention would not be necessary. Allergic reactions to radiopharmaceuticals are rare, but if they happen or are at risk of occurring, appropriate steps are given by the American College of Radiology, which includes preparation with corticosteroids and antihistamines as well as emergent medications&#x000a0;pending the development of any symptoms; these would include&#x000a0;epinephrine and labetalol.<xref ref-type="bibr" rid="article-24706.r12">[12]</xref></p>
      </sec>
      <sec id="article-24706.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The main purpose of scintimammography is to increase the positive predictive value of breast cancer detection with imaging to decrease the overall cost and improve the patient experience by minimizing the number of negative breast biopsies. Currently, scintimammography is not commonly used because of the prevalence of MRI for such examinations, as stated above. However, if additional research and discussion are performed to support its efficacy and use, it could be a valuable asset for the breast imaging world.<xref ref-type="bibr" rid="article-24706.r7">[7]</xref><xref ref-type="bibr" rid="article-24706.r13">[13]</xref><xref ref-type="bibr" rid="article-24706.r9">[9]</xref></p>
      </sec>
      <sec id="article-24706.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Scintimammography is a diagnostic imaging modality using radiopharmaceuticals to identify breast malignancies. With limited complications, allergic reaction to radiopharmaceuticals, and extravasation of radiopharmaceuticals, the most effective way of enhancing healthcare team outcomes is through identifying every step of the process and assigning a role to each team member. Prior to the patient arriving at the hospital or clinic for their examination, the following should be done:</p>
        <list list-type="bullet">
          <list-item>
            <p>Appropriate scheduling should be provided to the patient to allow for optimal patient satisfaction.</p>
          </list-item>
          <list-item>
            <p>Screening for a history of recent surgeries, menstrual cycle, recent imaging with radiopharmaceuticals, history of contrast/radiopharmaceutical reactions, and personal medical history should be administered. Appropriate preparation for the patient should be overseen by the radiologist.</p>
          </list-item>
          <list-item>
            <p>The nuclear medicine technician should perform quality control according to the general guidelines by the Society of Nuclear Medicine on the scintillation camera.</p>
          </list-item>
          <list-item>
            <p>The radiologist should review the imaging to understand the case better and ensure that the study meets the appropriate criteria.</p>
          </list-item>
          <list-item>
            <p>Radiopharmaceuticals of choice should be prepared and shipped within the appropriate timeframe to prevent radioactive decay.</p>
          </list-item>
        </list>
        <p>When these interprofessional roles have been assigned and are accomplished without interruption, the coordinated efforts of the entire interprofessional healthcare team,&#x000a0;including the patient,&#x000a0;demonstrate&#x000a0;an overall better experience and more positive outcomes. [Level 5]</p>
      </sec>
      <sec id="article-24706.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24706&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24706">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24706/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24706">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24706.s14">
        <title>References</title>
        <ref id="article-24706.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeSantis</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goding Sauer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Jemal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Breast cancer statistics, 2017, racial disparity in mortality by state.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>439</fpage>
            <page-range>439-448</page-range>
            <pub-id pub-id-type="pmid">28972651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>YCT</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Berenson</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Trends in breast cancer mortality by stage at diagnosis among young women in the United States.</article-title>
            <source>Cancer</source>
            <year>2018</year>
            <month>Sep</month>
            <day>01</day>
            <volume>124</volume>
            <issue>17</issue>
            <fpage>3500</fpage>
            <page-range>3500-3509</page-range>
            <pub-id pub-id-type="pmid">30189117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sondik</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Breast cancer trends. Incidence, mortality, and survival.</article-title>
            <source>Cancer</source>
            <year>1994</year>
            <month>Aug</month>
            <day>01</day>
            <volume>74</volume>
            <issue>3 Suppl</issue>
            <fpage>995</fpage>
            <page-range>995-9</page-range>
            <pub-id pub-id-type="pmid">8039156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saslow</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boetes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Harms</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leach</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pisano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schnall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sener</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Warner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yaffe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>CA</given-names>
              </name>
              <collab>American Cancer Society Breast Cancer Advisory Group</collab>
            </person-group>
            <article-title>American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2007</year>
            <season>Mar-Apr</season>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>75</fpage>
            <page-range>75-89</page-range>
            <pub-id pub-id-type="pmid">17392385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalkhali</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mena</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Diggles</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.</article-title>
            <source>Eur J Nucl Med</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>357</fpage>
            <page-range>357-62</page-range>
            <pub-id pub-id-type="pmid">8005161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <collab>Medical Advisory Secretariat</collab>
            <article-title>Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis.</article-title>
            <source>Ont Health Technol Assess Ser</source>
            <year>2007</year>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>1</fpage>
            <page-range>1-47</page-range>
            <pub-id pub-id-type="pmid">23074502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schillaci</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Buscombe</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Breast scintigraphy today: indications and limitations.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>31 Suppl 1</volume>
            <fpage>S35</fpage>
            <page-range>S35-45</page-range>
            <pub-id pub-id-type="pmid">15103505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krivorot'ko</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>[Diagnostic accuracy of mammography and mammoscintigraphy in multifocal breast cancer].</article-title>
            <source>Vopr Onkol</source>
            <year>2013</year>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-64</page-range>
            <pub-id pub-id-type="pmid">23805452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piwkowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zieli&#x00144;ska</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ko&#x00142;odziejczyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zawisza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zebrowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Patrzyk</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinical importance of (99m)Tc-MIBI mammoscintigraphy in multifocal breast lesions.</article-title>
            <source>Nucl Med Rev Cent East Eur</source>
            <year>2006</year>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>144</fpage>
            <page-range>144-6</page-range>
            <pub-id pub-id-type="pmid">17304478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanaev</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Krivorot'ko</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Novikov</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Semiglazov</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Semiglzova</surname>
                <given-names>TIu</given-names>
              </name>
              <name>
                <surname>Turkevich</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Zhukova</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Klimashevski&#x0012d;</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Ivantsov</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Donskikh</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Klimenko</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Briantseva</surname>
                <given-names>ZhV</given-names>
              </name>
            </person-group>
            <article-title>[Effectiveness of mammary scintigraphy for determining the results of neoadjuvant polychemotherapy in breast cancer].</article-title>
            <source>Vopr Onkol</source>
            <year>2013</year>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>328</fpage>
            <page-range>328-33</page-range>
            <pub-id pub-id-type="pmid">23909033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldsmith</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Guiberteau</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Lanzkowsky</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weigert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heston</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Buscombe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stabin</surname>
                <given-names>MG</given-names>
              </name>
              <collab>Society of Nuclear Medicine</collab>
            </person-group>
            <article-title>SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>219</fpage>
            <page-range>219-24</page-range>
            <pub-id pub-id-type="pmid">21057112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Pol</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>V&#x000f6;&#x000f6;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bucerius</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mottaghy</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>7</issue>
            <fpage>1234</fpage>
            <page-range>1234-1243</page-range>
            <pub-id pub-id-type="pmid">28303300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24706.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Novikov</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Chernaya</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Krzhivitsky</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Kanaev</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Krivorotko</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Artemyeva</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Popova</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title><sup>99m</sup>Tc-MIBI scintimammography and digital mammography in the diagnosis of multicentric breast cancer.</article-title>
            <source>Hell J Nucl Med</source>
            <year>2019</year>
            <season>Sep-Dec</season>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>172</fpage>
            <page-range>172-178</page-range>
            <pub-id pub-id-type="pmid">31587026</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
